Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome

International Journal of Cardiology

Volumn 124, Issue 3, 2008, Pages 326-331

  Dudek, Dariusz ^a   Rakowski, Tomasz ^a   El Massri, Nader ^a   Sorysz, Danuta ^a   Zalewski, Jaroslaw ^a   Legutko, Jacek ^a   Dziewierz, Artur ^a   Rzeszutko, Lukasz ^a   Zmudka, Krzysztof ^a   Piwowarska, Wieslawa ^a   De Luca, Giuseppe ^b   Kaluza, Grzegorz L ^c   Janion, Marianna ^d   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d Regional District Hospital   (Poland)

Author keywords

Facilitated PCI; Fibrinolysis; Infarct related artery; Myocardial infarction; Networking; Reperfusion

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR PATENCY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CARE UNITS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT TRANSFER; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VENTRICULAR FUNCTION, LEFT;

EID: 39749126844     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.02.008     Document Type: Article

References (27)

1. Waters II R.E., Singh K.P., Roe M.T., et al. Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 43 (2004) 2153-2159
2. Dalby M., Bouzamondo A., Lechat P., and Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108 (2003) 1809-1814
3. Dudek D., Zmudka K., Kaluza G.L., et al. Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals. Am J Cardiol 91 (2003) 227-229
4. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
5. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
6. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
7. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI 3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
8. De Luca G., Ernest N., Zijlstra F., et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 43 (2004) 1363-1367
9. Keeley E.C., Boura J.A., and Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 367 (2006) 579-588
10. Smith Jr. S.C., Blair S.N., Bonow R.O., et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 38 (2001) 1581-1583
11. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
12. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
13. Vermeer F., Oude Ophuis A.J., vd Berg E.J., et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 82 (1999) 426-431
14. Ross A.M., Coyne K.C., Reiner J.S., et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol 34 (1999) 1954-1962
15. Widimsky P., Groch L., Zelizko M., Aschermann M., Bednar F., and Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 21 (2000) 823-831
16. O'Neill W.W., Weintraub R., Grines C.L., et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation 86 (1992) 1710-1717
17. ASSENT-4 PCI Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction ASSENT-4 PCI): randomized trial. Lancet 367 (2006) 569-578
18. Antman E.M., et al., for the TIMI 14 Investigators. Abciximab facilitates the rate and extent of thrombolysis: results of TIMI 14 trial. Circulation 99 (1999) 2720-2732
19. Kastrati A., Mehilli J., Schlotterbeck K., et al. Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA 291 (2004) 947-954
20. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
21. Rezkalla S.H., and Kloner R.A. No-reflow phenomenon. Circulation 105 (2002) 656-662
22. Brodie B.R., Stuckey T.D., Hansen C., and Muncy D. Benefit of coronary reperfusion before intervention on outcome after primary angioplasty for acute myocardial infarction. Am J Cardiol 85 (2000) 13-18
23. Ndrepepa G., Kastrati A., Braun S., et al. Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. J Nucl Med 46 (2005) 1782-1788
24. The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomized trial. Lancet 357 (2001) 1905-1914
25. Dauerman H.L. The early days after ST-segment elevation acute myocardial infarction: reconsidering the delayed invasive approach. J Am Coll Cardiol 42 (2003) 420-423
26. Antman E.M., and Van de Werf F. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction. Circulation 109 (2004) 2480-2486
27. Dudek D., Dziewierz A., Rakowski T., et al. Time-to-reperfusion therapy influence outcome of patients with myocardial infarction subjected to facilitated PCI. Eurointervention 1 (2005) 309-314